118
Participants
Start Date
July 5, 2016
Primary Completion Date
July 25, 2018
Study Completion Date
July 25, 2018
brimonidine tartrate/timolol malate Ophthalmic Solution
One drop of brimonidine tartrate/timolol malate (COMBIGAN®) Ophthalmic Solution in the affected eye, administered twice daily for 12 months
bimatoprost ophthalmic solution 0.01%
Bimatoprost ophthalmic solution 0.01% (LUMIGAN®) administered once daily in the evening 5 minutes after COMBIGAN® instillation if additional lowering IOP is needed
Seoul National University Bundang Hospital, Seoul National University College of Medicine, Gyeonggi-do
Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon
Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu
Pusan National University Hospital, Pusan National University School of Medicine, Busan
Chonnam National University Hospital, Chonnam National University Medical School, Gwangju
Seoul National University Hospital, Seoul National University College of Medicine, Seoul
Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul
Kim's Eye Hospital, Konyang University College of Medicine, Seoul
Lead Sponsor
Allergan
INDUSTRY